Is a 1 mg oral dose of lorazepam (Ativan) equivalent to a 1 mg intravenous dose?

Oral and IV Lorazepam Are NOT Equivalent Doses

A 1 mg oral dose of lorazepam is essentially equivalent to a 1 mg intravenous dose in terms of total drug exposure, but the routes differ significantly in onset time and clinical application. The oral bioavailability of lorazepam is approximately 90-100%, meaning nearly all of an oral dose reaches systemic circulation 1, 2.

Key Pharmacokinetic Differences

Bioavailability

• Oral lorazepam has 95-100% absolute bioavailability 1
• This exceptionally high bioavailability means 1 mg PO delivers approximately the same total drug exposure as 1 mg IV
• Unlike many benzodiazepines, lorazepam undergoes minimal first-pass metabolism

Onset and Peak Effect

The critical difference lies in timing, not total dose:

• IV lorazepam: Onset 1-2 minutes, peak effect 3-5 minutes 3
• Oral lorazepam: Peak plasma levels at 2-3 hours post-dose 1, 4
• Sublingual lorazepam: Similar absorption to oral (peak ~2.4 hours), despite common misconceptions 1

Clinical Implications by Route

For acute agitation/delirium 5:

• IV/SC: 1 mg stat (up to 2 mg maximum)
• Lower doses (0.25-0.5 mg) in elderly, frail, or COPD patients
• Can also be given PO or sublingual, but expect delayed onset

For status epilepticus 3:

• IV: 0.05-0.15 mg/kg (maximum 5 mg single dose)
• Repeat hourly as necessary
• IV route is essential for seizure emergencies due to rapid onset

For procedural sedation 6:

• IV: Initial 1-2 mg over 1-2 minutes in adults <60 years
• Additional 1 mg doses at 2-minute intervals until adequate sedation
• Dose reduction of 20%+ for patients >60 years or ASA ≥3

Important Caveats

When Routes Are NOT Interchangeable

• Emergency situations requiring immediate effect: Only IV/IM routes are appropriate
• Status epilepticus: IV is the standard of care 7
• Severe acute agitation: IV/SC preferred for rapid control 5

Absorption Considerations

• IM lorazepam: Completely absorbed, peak at ~1 hour, absorption half-life ~14 minutes 1
• Oral/sublingual: Contrary to popular belief, sublingual offers no significant advantage over swallowed tablets in absorption speed 1

Duration of Effect

Regardless of route, lorazepam has:

• Elimination half-life: 12-14 hours 2, 1
• Duration of clinical effect: 15-80 minutes for sedation (IV), but anxiolytic effects persist much longer
• The route does not significantly alter elimination half-life 1

Special Populations Requiring Dose Adjustment

Elderly patients 2:

• 20% reduction in clearance
• Reduce initial doses by 20%+ regardless of route
• More sensitive to sedative effects

Renal impairment 2:

• Volume of distribution increased 40%
• Half-life prolonged 25%
• Total clearance unchanged, but glucuronide metabolite accumulates
• No specific dose adjustment for parent drug needed

Hepatic impairment 2:

• No significant effect on lorazepam clearance (glucuronidation preserved)
• Unlike oxidatively metabolized benzodiazepines (midazolam, diazepam)

Common Pitfall

The most common error is assuming sublingual administration provides faster onset than oral. Research demonstrates sublingual and oral lorazepam have nearly identical absorption profiles, with peak levels at ~2.4 hours for both 1. The IV route is the only option for rapid effect.

Bottom line: While 1 mg PO ≈ 1 mg IV in total drug exposure, choose the route based on urgency of clinical need. For emergencies requiring immediate effect (seizures, severe agitation), only parenteral routes are appropriate. For non-urgent anxiety or sedation, oral dosing is equivalent and preferred.